ID SOLUTIONS ONCOLOGY
LIVE

Serial Number

79410002

Owner

ID SOLUTIONS ONCOLOGY

Attorney

J. Scott Gerien

Filing Date

Sep 3, 2024

Add to watchlist:

No watchlists yet
View on USPTO

ID SOLUTIONS ONCOLOGY Trademark

Serial Number: 79410002 • Registration: 8105620

ID SOLUTIONS ONCOLOGY is a trademark filed by ID SOLUTIONS ONCOLOGY on September 3, 2024. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

ID SOLUTIONS ONCOLOGY

60 Avenue André Roussin

Entity Type: 34

Trademark Details

Filing Date

September 3, 2024

Registration Date

January 20, 2026

Published for Opposition

December 2, 2025

Goods & Services

Diagnostic test kits comprised of medical diagnostic agents, preparations and substances for detecting gene mutations implicated in cancers; in vitro test kits for detecting genetic defects for medical purposes; chemical preparations intended for use in DNA analysis for medical use; reagents for use in medical genetic testing; genetic identity tests comprising reagents for medical use; preparations for detecting genetic predispositions for medical use; reagents for nucleic acid amplification for medical use

Biochemical preparations, namely, precursors intended for in vitro genetic engineering; diagnostic reagents for in vitro use for biochemistry, clinical chemistry and microbiology; chemical preparations for scientific purposes intended for use in DNA analysis, other than for medical use; enzymes, other than for medical use, for continuous, homogeneous and isothermal amplification processes for DNA-specific models; chemical genetic identity tests comprised of reagents for nonmedical purposes; reagents for nucleic acid amplification other than for medical or veterinary use

Laboratory apparatus for detecting genetic sequences; quantitative polymerase chain reaction (PCR) instrument for scientific use, namely, thermal cycler; laboratory apparatus and automatic machines for purifying nucleic acids, not for medical purposes

DNA and RNA testing apparatus for medical use; genetic testing apparatus for medical use; quantitative polymerase chain reaction (PCR) instrument for medical use, namely, thermal cycler; samplers for medical use, namely, sample preparation device for medical diagnostic use; medical apparatus and automatic machines for purifying nucleic acids for medical use

Research with respect to DNA sequencing technology; research in the field of DNA analysis technology; scientific research in the field of genetics and genetic engineering; structural and functional analysis of genomes; software as a service (SaaS) featuring software for the design of probes and primers for quantitative polymerase chain reaction (PCR) and interpretation of quantitative polymerase chain reaction (PCR) results in the field of health; software as a service (SaaS) featuring software for the design of probes and primers for quantitative polymerase chain reaction (PCR) and interpretation of quantitative polymerase chain reaction (PCR) results in the field of biology; software as a service (SaaS) featuring software for the design of probes and primers for quantitative polymerase chain reaction (PCR) and interpretation of quantitative polymerase chain reaction (PCR) results in the field of in vitro diagnostics; design, development and maintenance of software in the field of health; design, development and maintenance of software in the field of biology; design, development and maintenance of software in the field of in vitro diagnostics.

Filing History

LIMITATION OF GOODS RECEIVED FROM IB
Jul 16, 2026 LIMG
NEW REPRESENTATIVE AT IB RECEIVED
Jun 4, 2026 NREP
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
May 7, 2026 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 20, 2026 OPNS
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 20, 2026 FICR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Apr 20, 2026 OPNR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 20, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Jan 20, 2026 R.PR
NOTIFICATION PROCESSED BY IB
Dec 11, 2025 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 2, 2025 NPUB
PUBLISHED FOR OPPOSITION
Dec 2, 2025 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 26, 2025 OPNS
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 26, 2025 NONP
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Nov 25, 2025 OP2R
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 30, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 4, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 4, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 4, 2025 TROA
REFUSAL PROCESSED BY IB
Jun 7, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 22, 2025 RFCS
REFUSAL PROCESSED BY MPU
May 22, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 27, 2025 RFCR
NON-FINAL ACTION WRITTEN
Mar 26, 2025 CNRT
ASSIGNED TO EXAMINER
Mar 6, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Dec 5, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 5, 2024 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Dec 4, 2024 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 21, 2024 REPR